Jonathan Rubin - 05 Mar 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
SVP, Chief Medical Officer
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
05 Mar 2025
Net transactions value
-$48,517
Form type
4
Filing time
05 Mar 2025, 16:14:47 UTC
Previous filing
24 Feb 2025
Next filing
12 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Tax liability $10,378 -314 -2.8% $33.05 10,789 05 Mar 2025 Direct F1
transaction SUPN Common Stock Tax liability $19,070 -577 -5.3% $33.05 10,212 05 Mar 2025 Direct F1
transaction SUPN Common Stock Tax liability $19,070 -577 -5.7% $33.05 9,635 05 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units.